{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T07:42:22Z","timestamp":1768722142741,"version":"3.49.0"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FP7-HEALTH (RESOLVE)","award":["305707"],"award-info":[{"award-number":["305707"]}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["91617027"],"award-info":[{"award-number":["91617027"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1006145","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T17:24:54Z","timestamp":1528392294000},"page":"e1006145","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["In vivo and in silico dynamics of the development of Metabolic Syndrome"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1812-7694","authenticated-orcid":true,"given":"Yvonne J. W.","family":"Rozendaal","sequence":"first","affiliation":[]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Yared","family":"Paalvast","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8659-684X","authenticated-orcid":true,"given":"Lauren L.","family":"Tambyrajah","sequence":"additional","affiliation":[]},{"given":"Zhuang","family":"Li","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2172-7394","authenticated-orcid":true,"given":"Ko","family":"Willems van Dijk","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-4988","authenticated-orcid":true,"given":"Patrick C. N.","family":"Rensen","sequence":"additional","affiliation":[]},{"given":"Jan A.","family":"Kuivenhoven","sequence":"additional","affiliation":[]},{"given":"Albert K.","family":"Groen","sequence":"additional","affiliation":[]},{"given":"Peter A. J.","family":"Hilbers","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9375-4730","authenticated-orcid":true,"given":"Natal A. W.","family":"van Riel","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of Metabolic Syndrome Report of the National Heart, Lung, and Blood Institute\/American Heart Association Conference on Scientific Issues Related to Definition","volume":"109","author":"SM Grundy","year":"2004","journal-title":"Circulation"},{"key":"ref2","unstructured":"International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome [Internet]. 2006. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.idf.org\/webdata\/docs\/IDF_Meta_def_final.pdf\" xlink:type=\"simple\">http:\/\/www.idf.org\/webdata\/docs\/IDF_Meta_def_final.pdf<\/ext-link>"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1741-7015-9-48","article-title":"Metabolic syndrome: definitions and controversies","volume":"9","author":"E Kassi","year":"2011","journal-title":"BMC Med"},{"key":"ref4","first-page":"79","article-title":"Global status report on noncommunicable diseases 2014","year":"2014"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/2230-8210.91175","article-title":"Changing definitions of metabolic syndrome","volume":"16","author":"RM Parikh","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2013.05.064","article-title":"Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999\u20132010","volume":"62","author":"H Beltr\u00e1n-S\u00e1nchez","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref7","article-title":"Metabolic Syndrome in Endocrine System","volume":"2","author":"P Vanita","year":"2011","journal-title":"J Diabetes Metab"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1161\/ATVBAHA.111.241919","article-title":"Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease","volume":"32","author":"C Rask-Madsen","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref9","article-title":"A clinical perspective of obesity, metabolic syndrome and cardiovascular disease","volume":"5","author":"TS Han","year":"2016","journal-title":"JRSM Cardiovasc Dis"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/943162","article-title":"A Comprehensive Review on Metabolic Syndrome","volume":"2014","author":"J Kaur","year":"2014","journal-title":"Cardiol Res Pract"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.amepre.2011.10.026","article-title":"Obesity and severe obesity forecasts through 2030","volume":"42","author":"EA Finkelstein","year":"2012","journal-title":"Am J Prev Med"},{"key":"ref12","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults","author":"L Abarca-G\u00f3mez","year":"2017","journal-title":"The Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1472-6823-14-9","article-title":"The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies","volume":"14","author":"JV van Vliet-Ostaptchouk","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.5888\/pcd14.160287","article-title":"Metabolic Syndrome Prevalence by Race\/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988\u20132012","volume":"14","author":"JX Moore","year":"2017","journal-title":"Prev Chronic Dis"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105056","article-title":"Prevalence of Metabolic Syndrome: Association with Risk Factors and Cardiovascular Complications in an Urban Population","volume":"9","author":"GC Moreira","year":"2014","journal-title":"PLoS ONE"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1464-5491.2012.03616.x","article-title":"Heterogeneity in sex differences in the metabolic syndrome in Dutch white, Surinamese African and South Asian populations","volume":"29","author":"C Agyemang","year":"2012","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.diabres.2008.05.011","article-title":"The metabolic syndrome identifies a heterogeneous group of metabolic component combinations in the Asia-Pacific region","volume":"81","author":"CMY Lee","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e1003509","DOI":"10.1371\/journal.pcbi.1003509","article-title":"An In-Silico Model of Lipoprotein Metabolism and Kinetics for the Evaluation of Targets and Biomarkers in the Reverse Cholesterol Transport Pathway","volume":"10","author":"J Lu","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1006\/jtbi.2000.2150","article-title":"A model of beta-cell mass, insulin, and glucose kinetics: pathways to diabetes","volume":"206","author":"B Topp","year":"2000","journal-title":"J Theor Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2337\/db13-1198","article-title":"The oral minimal model method","volume":"63","author":"C Cobelli","year":"2014","journal-title":"Diabetes"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1109\/TBME.2006.883792","article-title":"A system model of oral glucose absorption: validation on gold standard data","volume":"53","author":"C Dalla Man","year":"2006","journal-title":"IEEE Trans Biomed Eng"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s10439-009-9738-6","article-title":"A model of NEFA dynamics with focus on the postprandial state","volume":"37","author":"K Jelic","year":"2009","journal-title":"Ann Biomed Eng"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10439-006-9201-x","article-title":"Multi-scale computational model of fuel homeostasis during exercise: effect of hormonal control","volume":"35","author":"J Kim","year":"2007","journal-title":"Ann Biomed Eng"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e1002577","DOI":"10.1371\/journal.pcbi.1002577","article-title":"Quantifying the contribution of the liver to glucose homeostasis: a detailed kinetic model of human hepatic glucose metabolism","volume":"8","author":"M K\u00f6nig","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"26028","DOI":"10.1074\/jbc.M110.188987","article-title":"A hierarchical whole-body modeling approach elucidates the link between in vitro insulin signaling and in vivo glucose homeostasis","volume":"286","author":"E Nyman","year":"2011","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1089\/dia.2006.8.617","article-title":"Dynamic modeling of free fatty acid, glucose, and insulin: an extended \u201cminimal model.\u201d","volume":"8","author":"A Roy","year":"2006","journal-title":"Diabetes Technol Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e0135665","DOI":"10.1371\/journal.pone.0135665","article-title":"Model-Based Quantification of the Systemic Interplay between Glucose and Fatty Acids in the Postprandial State","volume":"10","author":"FLP Sips","year":"2015","journal-title":"PloS One"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e1002272","DOI":"10.1371\/journal.pcbi.1002272","article-title":"A Whole-Body Model for Glycogen Regulation Reveals a Critical Role for Substrate Cycling in Maintaining Blood Glucose Homeostasis","volume":"7","author":"K Xu","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s10439-006-9217-2","article-title":"A distributed model of carbohydrate transport and metabolism in the liver during rest and high-intensity exercise","volume":"35","author":"E Chalhoub","year":"2007","journal-title":"Ann Biomed Eng"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-4682-9-16","article-title":"Bariatric surgery and T2DM improvement mechanisms: a mathematical model","volume":"9","author":"P Toghaw","year":"2012","journal-title":"Theor Biol Med Model"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1752-0509-6-130","article-title":"A whole-body mathematical model of cholesterol metabolism and its age-associated dysregulation","volume":"6","author":"MT Mc Auley","year":"2012","journal-title":"BMC Syst Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/qjmed\/hcg040","article-title":"Deteriorating beta-cell function in type 2 diabetes: a long-term model","volume":"96","author":"A Bagust","year":"2003","journal-title":"QJM Mon J Assoc Physicians"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10928-006-9008-2","article-title":"A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus","volume":"33","author":"W de Winter","year":"2006","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1210\/en.2015-1564","article-title":"A Mathematical Model of the Pathogenesis, Prevention, and Reversal of Type 2 Diabetes","volume":"157","author":"J Ha","year":"2016","journal-title":"Endocrinology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e0192472","DOI":"10.1371\/journal.pone.0192472","article-title":"A long-term mechanistic computational model of physiological factors driving the onset of type 2 diabetes in an individual","volume":"13","author":"J Sarkar","year":"2018","journal-title":"PLOS ONE"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1752-0509-5-174","article-title":"Parameter adaptations during phenotype transitions in progressive diseases","volume":"5","author":"CA Tiemann","year":"2011","journal-title":"BMC Syst Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e1003166","DOI":"10.1371\/journal.pcbi.1003166","article-title":"Parameter trajectory analysis to identify treatment effects of pharmacological interventions","volume":"9","author":"CA Tiemann","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"20120084","DOI":"10.1098\/rsfs.2012.0084","article-title":"Applications of analysis of dynamic adaptations in parameter trajectories","volume":"3","author":"NAW van Riel","year":"2013","journal-title":"Interface Focus"},{"key":"ref39","first-page":"1153","article-title":"A systems biology approach reveals the physiological origin of hepatic steatosis induced by liver X receptor activation","volume":"29","author":"BS Hijmans","year":"2015","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"20150075","DOI":"10.1098\/rsfs.2015.0075","article-title":"Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetes","volume":"6","author":"E Nyman","year":"2016","journal-title":"Interface Focus"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/01.ATV.0000243925.65265.3c","article-title":"Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice","volume":"26","author":"M Westerterp","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref42","unstructured":"Leiden Metabolic Research Services. APOE*3-Leiden.CETP mouse: Translational model for Cardiovascular and Metabolic Diseases. 2016; Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/lprs.nl\/wp-content\/uploads\/2016\/01\/Leiden-Metabolic-Research-Services-Flyer.pdf\" xlink:type=\"simple\">http:\/\/lprs.nl\/wp-content\/uploads\/2016\/01\/Leiden-Metabolic-Research-Services-Flyer.pdf<\/ext-link>"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e63882","DOI":"10.1371\/journal.pone.0063882","article-title":"Both transient and continuous corticosterone excess inhibit atherosclerotic plaque formation in APOE*3-leiden.CETP mice","volume":"8","author":"HE Auvinen","year":"2013","journal-title":"PloS One"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1161\/CIRCULATIONAHA.107.761965","article-title":"Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin","volume":"117","author":"W de Haan","year":"2008","journal-title":"Circulation"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/01.CIR.0000086460.55494.AF","article-title":"Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin","volume":"108","author":"R Kleemann","year":"2003","journal-title":"Circulation"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/01.ATV.0000238348.05028.14","article-title":"Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol","volume":"26","author":"T Kooistra","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bcp.2012.06.020","article-title":"Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice","volume":"84","author":"Z Li","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/dom.12252","article-title":"APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome","volume":"16","author":"AM van den Hoek","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1476-5381.2008.00109.x","article-title":"The dual PPARalpha\/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice","volume":"156","author":"JWA van der Hoorn","year":"2009","journal-title":"Br J Pharmacol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/bph.12490","article-title":"Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration","volume":"171","author":"Y Wang","year":"2014","journal-title":"Br J Pharmacol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/ATVBAHA.107.142570","article-title":"Mouse models for atherosclerosis and pharmaceutical modifiers","volume":"27","author":"S Zadelaar","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2337\/db14-1125","article-title":"Salsalate activates brown adipose tissue in mice","volume":"64","author":"AD van Dam","year":"2015","journal-title":"Diabetes"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2013.tb00484.x","article-title":"Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training","volume":"3","author":"CK Roberts","year":"2013","journal-title":"Compr Physiol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-2891-7-10","article-title":"The underlying mechanisms for development of hypertension in the metabolic syndrome","volume":"7","author":"H Yanai","year":"2008","journal-title":"Nutr J"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"230868","DOI":"10.1155\/2013\/230868","article-title":"Hypertension in metabolic syndrome: vascular pathophysiology","volume":"2013","author":"Y Mendiz\u00e1bal","year":"2013","journal-title":"Int J Hypertens"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","article-title":"Overproduction of Very Low\u2013Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome","volume":"28","author":"M Adiels","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/pgmj.2004.025601","article-title":"Pathophysiology of dyslipidaemia in the metabolic syndrome","volume":"81","author":"GD Kolovou","year":"2005","journal-title":"Postgrad Med J"},{"key":"ref58","first-page":"856","article-title":"The Pathophysiology of Obesity and Its Clinical Manifestations","volume":"3","author":"RN Redinger","year":"2007","journal-title":"Gastroenterol Hepatol"},{"key":"ref59","unstructured":"Lutz TA, Woods SC. Overview of Animal Models of Obesity. Curr Protoc Pharmacol Editor Board SJ Enna Ed\u2014Chief Al. 2012;CHAPTER: Unit5.61. <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.1002\/0471141755.ph0561s58\" xlink:type=\"simple\">10.1002\/0471141755.ph0561s58<\/ext-link><\/comment>"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0022-2275(20)33370-8","article-title":"Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry","volume":"40","author":"MS Bosner","year":"1999","journal-title":"J Lipid Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2362.1987.tb01132.x","article-title":"Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population","volume":"17","author":"YA Kes\u00e4niemi","year":"1987","journal-title":"Eur J Clin Invest"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.mbs.2013.03.006","article-title":"Parameter uncertainty in biochemical models described by ordinary differential equations","volume":"246","author":"J Vanlier","year":"2013","journal-title":"Math Biosci"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1006145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T01:11:23Z","timestamp":1751677883000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1006145"}},"subtitle":[],"editor":[{"given":"Alison L.","family":"Marsden","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":62,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1006145","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]}}}